BENJAMIN BREWER: Open Payments
NPI 1235997784 · N CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $250 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $209 |
| Medtronic, Inc. | 1 | $165 |
| CorMedix Inc. | 1 | $104 |
| Amgen Inc. | 2 | $46 |
| Novo Nordisk Inc | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
Products named: TARPEYO, SYMPLICITY G3, DEFENCATH, TAVNEOS, Ozempic, Empaveli, IBSRELA, JYNARQUE.
Industry payments across SC — which companies pay providers there.
